-
Featured
Improving the Safety of Vena Caval Thrombectomy in Kidney Cancer with Tumor Thrombus Team Approach
Complete removal of a tumor thrombus resulting from venous tumor invasion is essential for eliminating the cancer in patients with advanced renal cell carcinoma (RCC). A multispecialty tumor thrombus team within an integrated practice can improve the safety of this intricate and extensive procedure.
-
Featured
Dusting Vs. Basketing: Strategies for Disintegrating Renal Stones
Dusting, a new protocol for treating kidney stones using recent laser technologies, has proven to deliver successful patient outcomes equal to those of traditional basketing, according to a study by the Endourology Disease Group for Excellence.
-
Featured
Benefits of Cytoreductive Nephrectomy with Targeted Cancer Therapy for Metastatic Renal Cell Cancer
Since the advent of targeted cancer therapies in the mid-2000s, there has been a dramatic reduction in cytoreductive nephrectomies. Dr. Michael Blute of Massachusetts General Hospital states that the reduction is concerning, since cytoreductive nephrectomy can provide a strong survival advantage to patients with metastatic disease.
-
Cardiorenal Biomarkers Predict Major Complications in Patients With Type 2 Diabetes and Chronic Kidney Disease
James L. Januzzi, MD, and colleagues showed that among people with type 2 diabetes and albuminuria, baseline and follow-up concentrations of four biomarkers of cardiorenal stress individually and collectively predicted the risk of heart failure, progression of kidney disease, and related outcomes.
-
Pharmacologic Management of Ureteral Stent–related Symptoms Should Be Personalized
Brian H. Eisner, MD, David Eugenio Hinojosa-Gonzalez, MD, and a colleague used a network meta-analysis to conduct the first head-to-head comparison of medication regimens for managing symptoms related to ureteral stents, finding the optimal choice depends on a patient's chief complaint.
-
Kidney Transplant Education Symposium Shares Advances
The Massachusetts General Hospital Transplant Center's kidney transplant education course will help multidisciplinary teams maximize favorable outcomes in more patients with kidney disease.
Kidney Contributors
-
Brian H. Eisner, MD
Co-Director, Kidney Stone Program, Massachusetts General Hospital, Associate Professor of Surgery, Harvard Medical School
Recent Article
Pharmacologic Management of Ureteral Stent–related Symptoms Should Be Personalized
-
-
Michael G. Fitzsimons, MD
Interim Director, Division of Cardiac Anesthesia, CABG Redesign Committee, CABG Redesign Pre-op Subcommittee chair
Recent Article
Improving the Safety of Vena Caval Thrombectomy in Kidney Cancer with Tumor Thrombus Team Approach -
Michael L. Blute, MD
Chief, Department of Urology, Walter S. Kerr, Jr., Professor of Surgery, Harvard Medical School
Recent Article
Orthotopic Neobladder Reconstruction Restores Quality of Life for Female Cystectomy Patients
-
Mukesh G. Harisinghani, MD
Director, Abdominal MRI, Department of Radiology, Massachusetts General Hospital
Recent Article
Review: Advances in Radiologic Staging of Colorectal Cancer
Urology Care at Mass General
The Department of Urology at Massachusetts General Hospital offers sophisticated, compassionate care and the most innovative treatments for patients with any type of urological condition.